Clinical Trial Update: Methadone for 'Adenocarcinopathic' Pain Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial of methadone for cancer-related pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Cancer Pain

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Cancer Pain, Adenocarcinoma | Phase 3 | Status: WITHDRAWN